Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States

RATIONALE & OBJECTIVE: Information regarding disparities in initiating sodium/glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) in patients with chronic kidney disease (CKD) is limited. We examined sociodemographic and clinical factors associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Julie Z., Weinhandl, Eric D., Carlson, Angeline M., St. Peter, Wendy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803841/
https://www.ncbi.nlm.nih.gov/pubmed/36593878
http://dx.doi.org/10.1016/j.xkme.2022.100564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803841/
https://www.ncbi.nlm.nih.gov/pubmed/36593878
http://dx.doi.org/10.1016/j.xkme.2022.100564

Ejemplares similares